Artemisinin-derived dimers as potential anticancer agents: Current developments, action mechanisms, and...

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Oncology

Background:

• Current anticancer drugs often cause severe side effects and lack specificity.
• Novel therapeutic agents with enhanced efficacy and safety are urgently needed.
• Artemisinin derivatives, particularly dimers, display significant anticancer activity.

Purpose of the Study:

• To review the anticancer potential of artemisinin-derived dimers.
• To explore the influence of linker structure on anticancer activity.
• To provide insights into the rational design of novel anticancer agents.

Main Methods:

• Literature review of artemisinin-derived dimers and their anticancer properties.
• Analysis of structure-activity relationships (SAR) concerning linker modifications.
• Discussion of proposed mechanisms of action for anticancer effects.

Main Results:

• Artemisinin-derived dimers exhibit potent in vitro and in vivo anticancer activity.
• The linker connecting artemisinin moieties critically impacts anticancer efficacy.
• Specific linker designs can enhance potency and potentially reduce side effects.

Conclusions:

• Artemisinin-derived dimers represent a promising class of anticancer compounds.
• Optimizing linker design is crucial for developing effective cancer therapies.
• Further research into SAR and mechanisms can guide the development of superior anticancer drugs.